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OBJECTIVES: The Cost Of Diabetes Type 2 In Poland
(CODIP) is multicenter, bottom-up designed, retrospec-
tive study aimed at evaluation of total cost of diabetes
type 2 in Poland. Study design reﬂects that of CODE 2
(Cost Of Diabetes in Europe Type 2) and allows for inter-
national comparison. METHODS: Three hundred three
patients diagnosed with type 2 diabetes mellitus (mean
age: 61, mean time from diagnosis: 10,86 year, males:
49%) were randomly selected from out-patients charts
databases and surveyed. Both patient and practitioner
questionnaires collected data from each patient on: clin-
ical characteristic, medical and other resources used,
quality of life. Total treatment costs were calculated using
drug retail and medical procedures prices. Indirect costs
were estimated by human capital approach. The impact
of complications on total costs was evaluated. Values 
are expressed in PLN and also presented in Euro value
(PPP value: €1 = 1.9 PLN). RESULTS: A total of 74.6%
patients presented comorbidities with coronary arteries
disease as most prevalent (20.5%). The total annual treat-
ment costs amounted to 6797 PLN (€3577), including
2460 PLN (€1295) of direct costs. The direct cost struc-
ture: 21% physicians consultations, 3% paramedics,
46% diabetic drug costs (insulin 63%, oral hypoglycemic
agents and glucagon 37%), hospital costs 29%, emer-
gency service 1%. Calculating expenditures for comor-
bidities direct costs increased up to 4390 PLN (€2310).
Mean cost for patients with no complications amounted
to 1892 PLN (€996). The indirect cost is mainly deter-
mined by early retirements or morbidity and relatives care
costs. CONCLUSIONS: Economic impact of diabetes
type 2 in Poland is considerable. Insulin prescription pat-
terns are responsible for large part of drug costs. Diabetes
complications are associated with signiﬁcant total costs
increase.
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OBJECTIVES: In a type 2 diabetes population, we cal-
culated retrospectively the hospital costs according to dif-
ferent body mass index (BMI). METHODS: We studied
a cohort (n = 2263) of type 2 diabetes patients in-
cluded up to February 2002 and having undergone at
least two visits. The cohort was stratiﬁed in 4 BMI 
groups calculated on the mean measured body weight:
18.5–24.9kg/m2 (normal), 25–29.9kg/m2 (overweight),
30–34.9kg/m2 (obese) and over 35kg/m2 (very obese).
Annual hospital costs per patient for each BMI group
were calculated by combining observed Health care
resource utilization and ofﬁcial costs data of the Diagno-
sis Related Group (DRG) system. Health care resource
considered and costs were related to management of 
diabetes (in-hospitalization, day care hospitalization) and
complications (myocardial infarction, angina pectoris,
transient ischaemic accident and stroke). RESULTS:
Number of patients per group was 399, 914, 625, and
325 for normal, overweight, obese, and very obese respec-
tively. Total annual hospital costs (in Euros) per patient
were 2357, 2645, 2779, and 2972 for normal, over-
weight, obese and very obese respectively. In each group,
the relative weight of in-hospitalization cost for manage-
ment of diabetes were 51.2%, 51%, 58.1%, and 64.4%
for normal, overweight, obese and very obese respec-
tively. In each group, the relative weight of cost of com-
plications were 8%, 10.8%, 7.3%, and 8.9% for normal,
overweight, obese and very obese respectively. CON-
CLUSIONS: We conﬁrm obese diabetic patients (BMI
above 25kg/m2) generate more hospital costs than non-
obese diabetic patients. According to the increase of BMI,
we note a progression of in-hospitalization costs for man-
agement of type 2 diabetes whereas the proportion of day
care hospitalization costs is decreasing. Higher is the
BMI, higher are costs dedicated to diabetes care. As oppo-
site, cost of complications remains stable whatever the
BMI. Prevention of complications in patient with high
BMI may be an explanation to this pattern of care.
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OBJECTIVES: To investigate determinants on use of
emergency department in elderly patients with DM. Dia-
betes mellitus (DM) is a common chronic condition that
affects about 10% elderly population in the US. The total
direct medical expenditures incurred by people with dia-
betes are estimated more than $44 billion. It is estimated
that individual over the age of 65 years account for
approximately two-thirds of all medical costs related to
diabetes. Despite fact that a number of studies have exam-
ined medical cost and service use in patients with DM,
little is know about use of emergency department 
in elderly patients with DM. METHODS: Using the
national representative data of Medicare Current Beneﬁ-
ciary Survey (MCBS) in 1999, 1646 fee-for-service
